You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

targeted therapy

Showing 76 - 100 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Castration-resistant Prostate Cancer Trial in Grand Rapids (SPECT/CT)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • SPECT/CT
  • Grand Rapids, Michigan
    BAMF Health
Apr 19, 2023

Prostate Cancer Stage I Trial in Torino (Katty focal therapy)

Completed
  • Prostate Cancer Stage I
  • Katty focal therapy
  • Torino, TO, Italy
    A.O.U. San Giovanni Battista Molinette
Jan 31, 2023

COPD Exacerbation, COPD Exacerbation Acute Trial (Titrated Oxygen, Standard Oxygen)

Not yet recruiting
  • COPD Exacerbation
  • COPD Exacerbation Acute
  • Titrated Oxygen
  • Standard Oxygen
  • (no location specified)
Feb 2, 2023

Thyroid Cancer, Medullary, Neuroendocrine Tumor of the Lung Grade 1 and 2, Neuroendocrine Tumor of the Thymus Grade 1 and 2

Recruiting
  • Thyroid Cancer, Medullary
  • +3 more
  • Basel, Switzerland
    University Hospital Basel, Clinic for radiology and nuclear medi
May 23, 2022

Unresectable Metastatic Colorectal Cancer Trial (Bifico combined with chemo plus targeted therapy, chemo plus targeted therapy)

Not yet recruiting
  • Unresectable Metastatic Colorectal Cancer
  • Bifico combined with chemotherapy plus targeted therapy
  • chemotherapy plus targeted therapy
  • (no location specified)
Jul 13, 2021

99mTc-DARPinG3 SPECT/CT for Non-invasive HER2-AX in Breast

Enrolling by invitation
  • Breast Cancer Female
  • 99mTc-DARPinG3 SPECT/CT
  • Tomsk, Russian Federation
    Russia Tomsk NRMC
Jan 23, 2023

Metastatic Clear Cell Renal Cell Carcinoma, With Positive PSMA Expression at Tumor Sites Trial (177Lu-PSMA-1

Not yet recruiting
  • Metastatic Clear Cell Renal Cell Carcinoma
  • With Positive PSMA Expression at Tumor Sites
  • 177Lu-PSMA-1 (radiopharmaceutical)
  • (no location specified)
Sep 26, 2023

HER2-positive Breast Cancer Trial in Birmingham ([18F]-FDG)

Recruiting
  • HER2-positive Breast Cancer
  • Birmingham, Alabama
    The University of Alabama at Birmingham
Jan 31, 2022

NSCLC Metastatic, Targetable Oncogenes (EGFR, ALK, ROS1) Trial in Boston (SBRT with protons or photons)

Active, not recruiting
  • Non-small Cell Lung Cancer Metastatic
  • Targetable Oncogenes (EGFR, ALK, ROS1)
  • SBRT with protons or photons
  • Boston, Massachusetts
    Massachusetts General Hospital
Dec 22, 2021

Thyroid Cancer, Medullary Trial in Basel (177Lu-PP-F11N, Sacuitril)

Completed
  • Thyroid Cancer, Medullary
  • Basel, Switzerland
    University Hospital Basel, Clinic for radiology and nuclear medi
Feb 9, 2022

Gastric Cancer and Establishment and Verification of Monitoring

Not yet recruiting
  • HER2 Positive Gastric Cancer
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Dec 14, 2021

    Prostate Cancer, Prostate Cancer Recurrent, Prostate Cancer Metastatic Trial in Leuven (Radiotherapy (SBRT) and/or surgery

    Recruiting
    • Prostate Cancer
    • +6 more
    • Radiotherapy (SBRT) and/or surgery (metastasectomy)
    • +2 more
    • Leuven, Belgium
      University Hospitals Leuven
    Jun 7, 2022

    Sepsis Trial in Damanhur (targeted antibiotics therapy)

    Recruiting
    • Sepsis
    • targeted antibiotics therapy
    • Damanhūr, Elbehairah, Egypt
      Rehab Hussein Werida
    Aug 11, 2022

    Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Shanghai (Primary debulking surgery, Neoadjuvant

    Not yet recruiting
    • Ovarian Cancer
    • +2 more
    • Primary debulking surgery
    • +2 more
    • Shanghai, China
      Zhongshan Hospital, Fudan University
    Jan 17, 2022

    Esophageal Cancer Trial in Dallas (Itraconazole)

    Active, not recruiting
    • Esophageal Cancer
    • Dallas, Texas
      Dallas VA Medical Center
    Nov 2, 2021

    Gastric Cancer, Colon Cancer, Pancreas Cancer Trial in Nanchang (CEA CAR-T cells)

    Recruiting
    • Gastric Cancer
    • +6 more
    • CEA CAR-T cells
    • Nanchang, Jiangxi, China
      The First Affiliated Hospital of Nanchang University
    Aug 23, 2023

    SLE (Systemic Lupus), Sjogren's Syndrome, Systemic Scleroderma Trial in Taiyuan (CD19 targeted CAR-T cells)

    Recruiting
    • SLE (Systemic Lupus)
    • +4 more
    • CD19 targeted CAR-T cells
    • Taiyuan, Shanxi, China
      Shanxi Bethune Hospital
    Sep 25, 2023

    Hepatocellular Carcinoma, Hepatocellular Cancer, Metastatic Hepatocellular Carcinoma Trial run by the NCI (Cyclophosphamide,

    Recruiting
    • Hepatocellular Carcinoma
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    Implantation ofAdvanced Practice Nurse in Complex Care Pathway

    Not yet recruiting
    • Myeloid Leukemia
    • Interviews
    • (no location specified)
    Jul 13, 2022

    Immune Checkpoint Inhibitor Monotherapy or Combined With

    Not yet recruiting
    • Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeting Drugs / Locoregional Therapy for Hepatocellular Carcinoma
    • Immune checkpoint inhibitor
    • Guangzhou, Guangdong, China
      Department of Minimally Invasive and Interventional Radiology, L
    Jan 30, 2023

    Prostate Cancer Trial in Glen Burnie, Omaha, Knoxville (PSMA-Targeted [In-111]-Labeled Trillium Compound, PTI-122)

    Recruiting
    • Prostate Cancer
    • PSMA-Targeted [In-111]-Labeled Trillium Compound
    • PTI-122
    • Glen Burnie, Maryland
    • +2 more
    Mar 21, 2023

    Unresectable Hepatocellular Carcinoma Trial in Nanchang (D-TACE, HAIC, Lenvatinib)

    Recruiting
    • Unresectable Hepatocellular Carcinoma
    • Nanchang, Jiangxi, China
      The Second Affiliated Hospital of Nanchang University
    Oct 14, 2022

    Relapse Multiple Myeloma, Refractory Multiple Myeloma Trial in Hangzhou (BCMA Targeted CAR T-cells)

    Recruiting
    • Relapse Multiple Myeloma
    • Refractory Multiple Myeloma
    • BCMA Targeted CAR T-cells
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital, Medical College, Zhejiang Univers
    Jun 18, 2022

    Cancer, Non Small Cell Lung Cancer Trial in Salt Lake City (PET Imaging, Erlotinib, Bevacizumab)

    Completed
    • Cancer
    • Non Small Cell Lung Cancer
    • PET Imaging
    • +2 more
    • Salt Lake City, Utah
      Huntsman Cancer Institute
    Dec 16, 2021

    Patients With Advanced Refractory Solid Tumors

    Not yet recruiting
    • Feasibility
    • +3 more
    • Targeted therapy
    • (no location specified)
    Dec 14, 2021